Securian Asset Management Inc. Sells 14,422 Shares of Corteva, Inc. $CTVA

Posted by Francis Steltz on May 13th, 2026

Securian Asset Management Inc. lessened its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 44.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,374 shares of the company’s stock after selling 14,422 shares during the period. Securian Asset Management Inc.’s holdings in Corteva were worth $1,232,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Activest Wealth Management raised its stake in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the period. JPL Wealth Management LLC bought a new stake in Corteva during the 3rd quarter worth approximately $25,000. Redmont Wealth Advisors LLC purchased a new stake in Corteva in the 3rd quarter worth approximately $29,000. Jackson Grant Investment Advisers Inc. boosted its holdings in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares during the period. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in shares of Corteva during the 3rd quarter valued at $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Wells Fargo & Company upped their price target on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Jefferies Financial Group boosted their target price on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. BNP Paribas Exane raised their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Oppenheimer boosted their price objective on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, UBS Group lifted their target price on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Thirteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $87.52.

Read Our Latest Stock Report on CTVA

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Corteva Stock Performance

NYSE:CTVA opened at $82.59 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The firm has a market cap of $55.24 billion, a PE ratio of 48.58, a price-to-earnings-growth ratio of 2.68 and a beta of 0.59. The business has a 50 day moving average price of $80.88 and a 200-day moving average price of $73.03.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts predict that Corteva, Inc. will post 3.7 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Corteva Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.